Vivus and Qsymia: The Oddest Drug Approval

More and Vivus and the peculiar timing of the approval of their new obesity therapy, now named Qsymia. OK, in addition to the article mentioned in the previous post, a video went up this evening at ABC news about the compound's availability, also before any word from the FDA. Not long afterwards, the agency released its official decision. I heard about both of these leaks via Adam Feuerstein on...